Dr. Sara Jane McGee, MD

Dr. McGee practices at Samaritan Hospital in Troy, New York, part of Trinity Health.

Dr. McGee's NPI, 1437144409, was assigned on September 15, 2005. Dr. McGee holds Pennsylvania license MD039590L.

Dr. McGee's primary practice is Samaritan Hospital, at 2215 Burdett Avenue, Troy, NY 12180 in Rensselaer County. The practice phone is (518) 427-3402.

Dr. McGee's primary practice is Samaritan Hospital in Troy, New York, part of Trinity Health. Dr. McGee is also affiliated with Reading Hospital. The medical group on file is Samaritan Hospital. Dmand AI also links Dr. McGee to 3 more hospitals, 4 medical groups and 1 group practice or clinic, each named with a free account. Dr. McGee's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McGee practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. McGee's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. McGee's licenses on file in 2 states: Pennsylvania and New Jersey.

CMS data shows 368 Medicare services from Dr. McGee across 5 procedure codes in 2024, for 264 Medicare patients. Medicare paid $25,457 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 264 Medicare patients who saw Dr. McGee in 2024. The largest group is 65 to 74, with 127 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McGee's median patient age at 72, with 47% women.

In 2024, Dr. McGee wrote 266 Medicare Part D claims for 85 patients. 86% of them were for generic drugs. CMS names the drug for 112 of them, across 5 drugs with 11 or more claims each, at $16,846 in total drug cost. In 2023, CMS named 123 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. McGee for performance year 2024, reported as part of a group. Dr. McGee accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 199 general payments to Dr. McGee from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Amgen Inc. paid the most, $616.